Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGalliford Try Regulatory News (GFRD)

Share Price Information for Galliford Try (GFRD)

Share Price is delayed by 15 minutes
Get Live Data
512.00    -10.00 (-1.92%)
Bid:
508.00
Ask:
511.00
Spread: 3.00 (0.591%)
Market Cap: £502.80m
GFRD Live PriceLast checked at - London Stock Exchange

Intraday Galliford Try Share Chart

Contract

10 Oct 2019 07:00

RNS Number : 3531P
Galliford Try PLC
10 October 2019
 

GALLIFORD TRY SECURES £340 MILLION WORTH OF WATER FRAMEWORKS

 

Galliford Try plc, announces that its Water business has been appointed to AMP7 frameworks worth approximately £340m to the company.

 

Galliford Try has been appointed by Southern Water as Delivery Partner for two of its design and build frameworks. Starting in 2020 and running for five years, they have a total value of £425m and Galliford Try's share of the business is anticipated to be worth approximately £240m. The value of the contract is subject to the final determination of Southern Water's business plan from Ofwat.

 

The frameworks cover capital investment schemes such as water and wastewater treatment works, upgrades in the western region in joint venture with Black & Veatch, as well as network schemes including pipelines and pumping stations in both the western and eastern regions in joint venture with Morrison Utility Services.

 

Galliford Try has also been appointed to Yorkshire Water's AMP7 frameworks. The total value of the frameworks is £1bn and Galliford Try expects to secure about £100m of work over the five-year term. There is scope for a three-year extension. Working with design partner GHD, Galliford Try has been allocated to the 'complex civils' framework covering the design, build and refurbishment of clean and wastewater treatment assets, reservoirs and pumping stations.

 

Graham Prothero, Chief Executive of Galliford Try plc, commented: "The Water sector is a key strategic focus for our construction business as set out in our recent results. We are delighted to have been appointed to these frameworks having established an excellent relationship with Southern Water and Yorkshire Water over previous AMPs. We look forward to working with them to improve the service they provide to their customers."

 

 

For further enquiries please contact:

 

Galliford Try

 

Graham Prothero, Chief Executive

Andrew Duxbury, Finance Director

Kevin Corbett, General Counsel & Company Secretary

01895 855001

 

 

Galliford Try plc is a leading UK housebuilding, regeneration and construction group. It is listed on the London Stock Exchange and a member of the FTSE 250. Housebuilding - through our Linden Homes business - develops private and affordable homes in prime locations. Galliford Try Partnerships - our regeneration business - delivers mixed-tenure solutions working with housing association, local authority and private sector partners. Operating as Galliford Try and Morrison Construction, our Construction business carries out building and infrastructure with clients in the public, private and regulated sectors. At the end of the last financial year to 30 June 2019, the Group generated revenue of £2.8bn.

 

 

10 October 2019

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
CNTEKLFBKBFXFBD
Date   Source Headline
17th Jan 202010:09 amRNSHolding(s) in Company
9th Jan 20207:00 amRNSTrading Statement
8th Jan 202010:00 amRNSHolding(s) in Company
6th Jan 202012:06 pmRNSHolding(s) in Company
3rd Jan 20207:10 amRNSConfirmation of appointment of Chief Executive
3rd Jan 20207:01 amRNSCompletion of Disposal & Admission of Shares
3rd Jan 20207:00 amRNSCompletion of Acquisition
2nd Jan 20205:48 pmRNSScheme of Arrangement Effective
2nd Jan 202010:30 amRNSTotal Voting Rights
2nd Jan 20207:00 amRNSShare Exchange Ratio & Listing Application Details
31st Dec 201910:13 amRNSPublication of Supplementary Prospectus
27th Dec 20199:47 amRNSHolding(s) in Company
23rd Dec 201911:00 amRNSSettlement of AWPR
20th Dec 20196:00 pmRNSGalliford Try
19th Dec 20194:00 pmRNSDirector/PDMR Shareholding
19th Dec 201910:00 amRNSBlock Listing Application
17th Dec 20191:33 pmRNSCourt Sanction of Scheme of Arrangement
16th Dec 20194:00 pmRNSDirector/PDMR Shareholding
12th Dec 20194:00 pmRNSDirector/PDMR Shareholding
29th Nov 201912:12 pmRNSResults of Court Meeting and General Meeting
27th Nov 201912:00 pmRNSBlock listing Interim Review
25th Nov 201912:55 pmRNSPublication of Prospectus
19th Nov 20193:00 pmRNSDirector/PDMR Shareholding
12th Nov 20194:32 pmRNSResult of AGM
12th Nov 20197:00 amRNSAGM Statement
8th Nov 201912:19 pmRNSPublication of Circular
7th Nov 20197:00 amRNSSale of Housing Businesses
7th Nov 20197:00 amRNSAcquisition Update
10th Oct 20197:00 amRNSContract
3rd Oct 20192:00 pmRNSAnnual Financial Report
1st Oct 20193:30 pmRNSDirector/PDMR Shareholding
24th Sep 20193:00 pmRNSDirector/PDMR Shareholding
24th Sep 20197:00 amRNSContract
23rd Sep 20193:48 pmRNSHolding(s) in Company
20th Sep 20193:15 pmRNSHolding(s) in Company
20th Sep 20193:00 pmRNSDirector/PDMR Shareholding
11th Sep 20197:00 amRNSFinal Results
10th Sep 20197:00 amRNSStatement re Potential Combination
30th Jul 20193:48 pmRNSHolding(s) in Company
19th Jul 20192:45 pmRNSHolding(s) in Company
17th Jul 20192:52 pmRNSHolding(s) in Company
17th Jul 20197:00 amRNSTrading Statement
5th Jul 201912:03 pmRNSHolding(s) in Company
26th Jun 20191:40 pmRNSHolding(s) in Company
19th Jun 20193:36 pmRNSHolding(s) in Company
3rd Jun 20192:00 pmRNSHolding(s) in Company
28th May 201912:00 pmRNSBlock Listing Interim Review
28th May 20199:00 amRNSHolding(s) in Company
28th May 20197:00 amRNSDirector Declaration
28th May 20197:00 amRNSStatement re media speculation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.